Prognostic false-positivity and cost-effectiveness in sentinel node biopsy in melanoma
Ann Surg Oncol
.
2009 Oct;16(10):2961; author reply 2962-3.
doi: 10.1245/s10434-009-0587-1.
Epub 2009 Jul 1.
Author
J Meirion Thomas
PMID:
19568814
DOI:
10.1245/s10434-009-0587-1
No abstract available
Publication types
Comment
Letter
MeSH terms
Cost-Benefit Analysis
False Positive Reactions
Humans
Melanoma / economics*
Melanoma / surgery
Prognosis
Sentinel Lymph Node Biopsy / economics*